(Q44159478)

English

A 3-month course of long-acting repeatable octreotide (sandostatin LAR) improves portal hypertension in patients with cirrhosis: a randomized controlled study

scientific article published on 3 May 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

A 3-month course of long-acting repeatable octreotide (sandostatin LAR) improves portal hypertension in patients with cirrhosis: a randomized controlled study (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

portal hypertension

1 reference

based on heuristic

inferred from title

author name string

Laurent Spahr

1

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Emiliano Giostra

2

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Jean-Louis Frossard

3

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Isabelle Morard

4

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Gilles Mentha

5

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Antoine Hadengue

6

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

language of work or name

0 references

publication date

3 May 2007

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

The American Journal of Gastroenterology

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

102

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

1397-1405

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Complications of portal hypertension in adults: a French consensus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01262.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01262.X

21 January 2018

Acute hemodynamic effects of octreotide and terlipressin in patients with cirrhosis: a randomized comparison

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01262.X

21 January 2018

Octreotide for acute esophageal variceal bleeding: a meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01262.X

21 January 2018

Somatostatin or octreotide in acute variceal bleeding

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01262.X

21 January 2018

Validation of color Doppler EUS for azygos blood flow measurement in patients with cirrhosis: application to the acute hemodynamic effects of somatostatin, octreotide, or placebo

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01262.X

21 January 2018

Effects of long-term propranolol and octreotide on postprandial hemodynamics in cirrhosis: a randomized, controlled trial.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01262.X

21 January 2018

Effect of somatostatin and octreotide on proliferation and vascular endothelial growth factor secretion from murine endothelial cell line (HECa10) culture

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01262.X

21 January 2018

Chronic administration of octreotide ameliorates portal hypertension and portal hypertensive gastropathy in rats with cirrhosis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01262.X

21 January 2018

Effects of a long-acting formulation of octreotide on renal function and renal sodium handling in cirrhotic patients with portal hypertension: a randomized, double-blind, controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01262.X

21 January 2018

Randomised trial of octreotide for long term management of cirrhosis after variceal haemorrhage

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01262.X

21 January 2018

Hepatic vein pressure gradient reduction and prevention of variceal bleeding in cirrhosis: a systematic review

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01262.X

21 January 2018

The hepatic venous pressure gradient: anything worth doing should be done right

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01262.X

21 January 2018

Nitric oxide and portal hypertension

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01262.X

21 January 2018

Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01262.X

21 January 2018

Octreotide for cirrhosis after variceal bleeding. Authors' claims for octreotide were not justified

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01262.X

21 January 2018

Portal hypertension and ascites in acute hepatitis: clinical, hemodynamic and histological correlations

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01262.X

21 January 2018

Relationship between degree of portal hypertension and liver histologic lesions in patients with alcoholic cirrhosis. Effect of acute alcoholic hepatitis on portal hypertension.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01262.X

21 January 2018

Long-term prognosis of patients with alcoholic liver cirrhosis: a 15-year follow-up study of 100 Norwegian patients admitted to one unit

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01262.X

21 January 2018

Wedged hepatic venous pressure adequately reflects portal pressure in hepatitis C virus-related cirrhosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01262.X

21 January 2018

Pharmacological treatment of portal hypertension: hemodynamic effects and prevention of bleeding

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01262.X

21 January 2018

Randomized comparison of long-term losartan versus propranolol in lowering portal pressure in cirrhosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01262.X

21 January 2018

Desensitization to the effects of intravenous octreotide in cirrhotic patients with portal hypertension

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01262.X

21 January 2018

Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01262.X

21 January 2018

Octreotide long-term treatment in patients with portal hypertension: persistent inhibition of postprandial glucagon response without major changes in renal function.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01262.X

21 January 2018

Octreotide potentiates PKC-dependent vasoconstrictors in portal-hypertensive and control rats

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01262.X

21 January 2018

Endothelin-1 contributes to maintenance of systemic but not portal haemodynamics in patients with early cirrhosis: a randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01262.X

21 January 2018

Review article: angiogenesis soluble factors as liver disease markers

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01262.X

21 January 2018

Inhibition of VEGF receptor-2 decreases the development of hyperdynamic splanchnic circulation and portal-systemic collateral vessels in portal hypertensive rats.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2007.01262.X

21 January 2018

Identifiers

10.1111/J.1572-0241.2007.01262.X

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

release_tedg7hrk3bfydan456adtvzdwu

1 reference

https://api.fatcat.wiki/v0/release/tedg7hrk3bfydan456adtvzdwu

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44159478&oldid=2107280821"